Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli | 13 | 2024 | 994 | 2.800 |
Why?
|
| DNA, Superhelical | 8 | 2024 | 22 | 2.290 |
Why?
|
| Fluoroquinolones | 8 | 2013 | 97 | 2.150 |
Why?
|
| Drug Resistance, Bacterial | 7 | 2018 | 382 | 1.690 |
Why?
|
| Anti-Bacterial Agents | 11 | 2019 | 2558 | 1.510 |
Why?
|
| DNA | 10 | 2024 | 1473 | 1.450 |
Why?
|
| Klebsiella pneumoniae | 3 | 2016 | 85 | 1.320 |
Why?
|
| Ciprofloxacin | 4 | 2018 | 67 | 1.000 |
Why?
|
| Klebsiella Infections | 2 | 2016 | 60 | 0.960 |
Why?
|
| Base Pairing | 1 | 2021 | 42 | 0.720 |
Why?
|
| Endodeoxyribonucleases | 1 | 2021 | 46 | 0.710 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 930 | 0.670 |
Why?
|
| Microbial Sensitivity Tests | 10 | 2019 | 827 | 0.650 |
Why?
|
| DNA Replication | 3 | 2017 | 353 | 0.610 |
Why?
|
| Sugars | 1 | 2019 | 17 | 0.600 |
Why?
|
| Plasmids | 3 | 2016 | 459 | 0.590 |
Why?
|
| Escherichia coli Infections | 3 | 2012 | 192 | 0.580 |
Why?
|
| Iron | 2 | 2019 | 302 | 0.560 |
Why?
|
| Escherichia coli Proteins | 3 | 2024 | 316 | 0.540 |
Why?
|
| DNA Ligases | 1 | 2017 | 16 | 0.540 |
Why?
|
| Acinetobacter baumannii | 2 | 2019 | 47 | 0.530 |
Why?
|
| Orthomyxoviridae | 1 | 2016 | 52 | 0.500 |
Why?
|
| beta-Lactam Resistance | 1 | 2016 | 48 | 0.480 |
Why?
|
| beta-Lactamases | 2 | 2016 | 207 | 0.470 |
Why?
|
| Nucleic Acid Conformation | 6 | 2023 | 182 | 0.460 |
Why?
|
| Bacterial Infections | 1 | 2018 | 323 | 0.450 |
Why?
|
| Virulence Factors | 1 | 2016 | 187 | 0.450 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2019 | 149 | 0.440 |
Why?
|
| RNA, Viral | 1 | 2016 | 562 | 0.430 |
Why?
|
| Bacteria | 1 | 2018 | 524 | 0.420 |
Why?
|
| Drug Repositioning | 1 | 2013 | 31 | 0.410 |
Why?
|
| Ofloxacin | 3 | 2012 | 31 | 0.390 |
Why?
|
| Levofloxacin | 3 | 2012 | 47 | 0.390 |
Why?
|
| DNA Topoisomerases, Type II | 2 | 2010 | 25 | 0.380 |
Why?
|
| Pyridones | 1 | 2013 | 134 | 0.380 |
Why?
|
| Norfloxacin | 2 | 2008 | 4 | 0.370 |
Why?
|
| Mutation | 6 | 2019 | 6229 | 0.360 |
Why?
|
| Shear Strength | 1 | 2011 | 17 | 0.360 |
Why?
|
| Genotype | 2 | 2016 | 2697 | 0.340 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 346 | 0.340 |
Why?
|
| Respiratory Syncytial Virus, Human | 3 | 2022 | 233 | 0.340 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 2 | 2021 | 71 | 0.330 |
Why?
|
| DNA, Circular | 3 | 2023 | 16 | 0.320 |
Why?
|
| Transcriptome | 1 | 2016 | 1125 | 0.320 |
Why?
|
| DNA Gyrase | 3 | 2024 | 26 | 0.310 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 173 | 0.310 |
Why?
|
| Models, Molecular | 7 | 2018 | 1116 | 0.280 |
Why?
|
| DNA Topoisomerases | 1 | 2007 | 4 | 0.270 |
Why?
|
| Replicon | 1 | 2007 | 6 | 0.270 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2007 | 19 | 0.270 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2021 | 377 | 0.270 |
Why?
|
| Models, Chemical | 2 | 2021 | 88 | 0.260 |
Why?
|
| Proteins | 1 | 2012 | 1036 | 0.260 |
Why?
|
| Galactose | 2 | 2019 | 55 | 0.250 |
Why?
|
| Recombination, Genetic | 1 | 2007 | 441 | 0.240 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2018 | 23 | 0.220 |
Why?
|
| Hydrodynamics | 1 | 2023 | 28 | 0.200 |
Why?
|
| DNA Cleavage | 1 | 2021 | 8 | 0.180 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 173 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 354 | 0.170 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 75 | 0.160 |
Why?
|
| Genomic Instability | 1 | 2021 | 245 | 0.160 |
Why?
|
| Genetic Vectors | 3 | 2016 | 925 | 0.160 |
Why?
|
| Enterobactin | 1 | 2019 | 2 | 0.150 |
Why?
|
| Klebsiella | 1 | 2019 | 10 | 0.150 |
Why?
|
| Siderophores | 1 | 2019 | 10 | 0.150 |
Why?
|
| Genetic Therapy | 3 | 2016 | 719 | 0.150 |
Why?
|
| Models, Genetic | 1 | 2021 | 771 | 0.140 |
Why?
|
| DNA, Catenated | 1 | 2018 | 3 | 0.140 |
Why?
|
| Sulfolobus solfataricus | 1 | 2018 | 3 | 0.140 |
Why?
|
| Archaeal Proteins | 1 | 2018 | 8 | 0.140 |
Why?
|
| DNA Repair | 1 | 2021 | 565 | 0.140 |
Why?
|
| Genes, Bacterial | 1 | 2019 | 217 | 0.140 |
Why?
|
| Enterobacteriaceae | 1 | 2017 | 41 | 0.130 |
Why?
|
| Humans | 16 | 2022 | 132062 | 0.130 |
Why?
|
| Base Sequence | 4 | 2018 | 2899 | 0.130 |
Why?
|
| Philippines | 1 | 2016 | 23 | 0.120 |
Why?
|
| Antifungal Agents | 1 | 2019 | 312 | 0.120 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2016 | 33 | 0.120 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 62 | 0.120 |
Why?
|
| Carbapenems | 1 | 2016 | 43 | 0.120 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 146 | 0.120 |
Why?
|
| Genes | 1 | 2016 | 313 | 0.120 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 257 | 0.110 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 120 | 0.110 |
Why?
|
| Gene Fusion | 1 | 2014 | 60 | 0.110 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 90 | 0.110 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 165 | 0.110 |
Why?
|
| DNA Damage | 1 | 2017 | 511 | 0.110 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 30 | 0.100 |
Why?
|
| Microbial Viability | 1 | 2013 | 42 | 0.100 |
Why?
|
| Transfection | 2 | 2016 | 996 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 687 | 0.100 |
Why?
|
| Drug Resistance, Microbial | 1 | 2013 | 196 | 0.100 |
Why?
|
| Hospitals | 1 | 2016 | 438 | 0.100 |
Why?
|
| DNA Topoisomerase IV | 2 | 2012 | 13 | 0.100 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 124 | 0.100 |
Why?
|
| Cells | 1 | 2012 | 24 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2017 | 803 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 306 | 0.090 |
Why?
|
| Sonication | 1 | 2011 | 9 | 0.090 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 494 | 0.090 |
Why?
|
| Gene Expression | 1 | 2016 | 1558 | 0.090 |
Why?
|
| Aerosols | 1 | 2011 | 64 | 0.090 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2011 | 59 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 7102 | 0.090 |
Why?
|
| Antibodies, Viral | 3 | 2022 | 1203 | 0.090 |
Why?
|
| Viral Fusion Proteins | 2 | 2021 | 76 | 0.080 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2010 | 26 | 0.080 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2010 | 47 | 0.080 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2010 | 117 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2010 | 187 | 0.080 |
Why?
|
| Cryoelectron Microscopy | 2 | 2024 | 242 | 0.080 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 180 | 0.080 |
Why?
|
| Prevalence | 1 | 2016 | 2658 | 0.080 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 24 | 0.070 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2007 | 15 | 0.070 |
Why?
|
| Hospitals, County | 1 | 2008 | 22 | 0.070 |
Why?
|
| Kinetics | 2 | 2021 | 1130 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 2 | 2021 | 501 | 0.070 |
Why?
|
| United States | 2 | 2016 | 11658 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2007 | 365 | 0.060 |
Why?
|
| Texas | 2 | 2021 | 3629 | 0.060 |
Why?
|
| Computer Simulation | 3 | 2017 | 697 | 0.060 |
Why?
|
| Peptides | 2 | 2021 | 847 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2849 | 0.050 |
Why?
|
| Aged | 2 | 2016 | 21406 | 0.050 |
Why?
|
| Static Electricity | 2 | 2017 | 47 | 0.050 |
Why?
|
| Sex Factors | 1 | 2008 | 1353 | 0.050 |
Why?
|
| Ultracentrifugation | 1 | 2023 | 21 | 0.050 |
Why?
|
| Phenotype | 1 | 2013 | 4529 | 0.050 |
Why?
|
| Protein Domains | 1 | 2024 | 260 | 0.050 |
Why?
|
| Adult | 4 | 2022 | 31568 | 0.050 |
Why?
|
| Male | 3 | 2016 | 64922 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2438 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 9957 | 0.040 |
Why?
|
| Female | 3 | 2016 | 70712 | 0.040 |
Why?
|
| Age Factors | 1 | 2008 | 2912 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2021 | 274 | 0.040 |
Why?
|
| Seasons | 1 | 2022 | 327 | 0.040 |
Why?
|
| Mice | 1 | 2016 | 18507 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2021 | 14751 | 0.040 |
Why?
|
| Animals | 2 | 2017 | 34882 | 0.040 |
Why?
|
| DNA, Archaeal | 1 | 2018 | 4 | 0.040 |
Why?
|
| DNA, Concatenated | 1 | 2018 | 5 | 0.040 |
Why?
|
| Torsion, Mechanical | 1 | 2017 | 6 | 0.030 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 69 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 2017 | 40 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2018 | 141 | 0.030 |
Why?
|
| Electroporation | 1 | 2016 | 34 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 3014 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 3681 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 397 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 396 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2016 | 731 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2008 | 8549 | 0.030 |
Why?
|
| Fluorescence | 1 | 2014 | 101 | 0.030 |
Why?
|
| Child | 2 | 2021 | 25789 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2014 | 153 | 0.030 |
Why?
|
| Infant | 1 | 2008 | 13064 | 0.020 |
Why?
|
| Quinolones | 1 | 2012 | 58 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 183 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 321 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 311 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6567 | 0.020 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2009 | 16 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 540 | 0.020 |
Why?
|
| Adolescent | 1 | 2008 | 20562 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 792 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 615 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2009 | 259 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 1548 | 0.020 |
Why?
|
| Middle Aged | 1 | 2008 | 28964 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 1256 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1729 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 2508 | 0.010 |
Why?
|